Walvax Biotechnology Co., Ltd. (SHE:300142)
China · Delayed Price · Currency is CNY 12.41
+0.27 (2.22%)
Sep 5, 2025, 3:04 PM CST
Walvax Biotechnology Market Cap
Walvax Biotechnology has a market cap or net worth of 19.85 billion as of September 5, 2025. Its market cap has increased by 9.92% in one year.
Market Cap
19.85B
Enterprise Value
18.75B
Revenue
2.54B
Ranking
n/a
PE Ratio
1,344.66
Stock Price
12.41
Market Cap Chart
Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 19.85B, an increase of 45.57%. That is a compound annual growth rate of 2.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 19.85B | 2.73% |
| Dec 31, 2024 | 19.32B | -48.62% |
| Dec 29, 2023 | 37.60B | -41.50% |
| Dec 30, 2022 | 64.27B | -28.12% |
| Dec 31, 2021 | 89.42B | 50.25% |
| Dec 31, 2020 | 59.52B | 19.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 482.35B |
| WuXi AppTec | 313.22B |
| Shenzhen Mindray Bio-Medical Electronics | 287.79B |
| Sichuan Biokin Pharmaceutical | 155.60B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.00B |
| Aier Eye Hospital Group | 120.10B |
| Shanghai United Imaging Healthcare | 116.97B |
| Yunnan Baiyao Group Co.,Ltd | 105.81B |